Complement Inhibition in Cancer Therapy

Seminars in Immunology - United States
doi 10.1016/j.smim.2013.04.001
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Inhibition of Histone Deacetylases in Cancer Therapy: Lessons From Leukaemia

British Journal of Cancer
Cancer ResearchOncology
2016English

Complement-Mediated Mechanisms in Anti-Gd2 Monoclonal Antibody Therapy of Murine Metastatic Cancer

Cancer Research
Cancer ResearchOncology
2005English

In Vitro Inhibition of Canine Complement-Mediated Hemolysis

Journal of Veterinary Internal Medicine
MedicineVeterinary
2017English

Efficacy of Targeted Complement Inhibition in Experimental C3 Glomerulopathy

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2015English

Toward Complement Inhibition 2.0: Next Generation Anti-Complement Agents for Paroxysmal Nocturnal Hemoglobinuria

American Journal of Hematology
Hematology
2018English

Can We Unlock the Potential of IGF-1R Inhibition in Cancer Therapy?

Cancer Treatment Reviews
MedicineOncologyRadiologyNuclear MedicineImaging
2014English

Autophagy Inhibition Mediates Apoptosis Sensitization in Cancer Therapy by Relieving FOXO3a Turnover

Developmental Cell
BiochemistryDevelopmental BiologyGeneticsCell BiologyMolecular Biology
2018English

Rho-Associated Kinases in Tumorigenesis: Re-Considering ROCK Inhibition for Cancer Therapy

EMBO Reports
BiochemistryGeneticsMolecular Biology
2012English

Polo-Like Kinase 4 Inhibition: A Strategy for Cancer Therapy?

Cancer Cell
Cancer ResearchOncologyCell Biology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy